Atlas Trials

Tuscaloosa Research & Education Advancement Corporation

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Tuscaloosa Research & Education Advancement Corporation

RecordFirmDate
Minds Navigating the Diagnosis of Mild Cognitive Impairment (NCT05690243)Tuscaloosa Research & Education Advancement Corporation2023-10-01
Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans (NCT00659230)Tuscaloosa Research & Education Advancement Corporation2009-07-01
Alabama Veterans Rural Health Initiative (NCT01394081)Tuscaloosa Research & Education Advancement Corporation2008-10-01
Impact of Supported Employment Versus Standard Vocational Rehabilitation in Veterans With Post-traumatic Stress Disorder (NCT00728325)Tuscaloosa Research & Education Advancement Corporation2008-05-01
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia (NCT00315900)Tuscaloosa Research & Education Advancement Corporation2006-05-01
Divalproex vs. Lamotrigine for Bipolar Disorder (NCT00451542)Tuscaloosa Research & Education Advancement Corporation2006-02-01
Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade (NCT00233467)Tuscaloosa Research & Education Advancement Corporation2005-09-01
Carbamazepine Extended-Release for the Treatment of Bipolar Depression (NCT00203567)Tuscaloosa Research & Education Advancement Corporation2005-08-01
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years (NCT00230893)Tuscaloosa Research & Education Advancement Corporation2005-07-01
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction (NCT00203476)Tuscaloosa Research & Education Advancement Corporation2005-05-01
Characterization of Recently Deployed Veterans (NCT00451659)Tuscaloosa Research & Education Advancement Corporation2005-02-01
Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder (NCT00203528)Tuscaloosa Research & Education Advancement Corporation2004-01-01
Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial (NCT00203450)Tuscaloosa Research & Education Advancement Corporation2003-05-01
Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder (NCT00203385)Tuscaloosa Research & Education Advancement Corporation2003-05-01
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD) (NCT00203463)Tuscaloosa Research & Education Advancement Corporation2001-07-01

Track Tuscaloosa Research & Education Advancement Corporation automatically

Every clearance here is in the API, with alerts when new ones post.